Status:
RECRUITING
A Prospective, Single-arm, Multi-centre, Blinded, Observational, Diagnostic Accuracy Study With a Diagnostic Medical Product
Lead Sponsor:
ISAR-M GmbH
Collaborating Sponsors:
CRI-The Clinical Research Institute GmbH
Conditions:
Thyroid
Eligibility:
All Genders
18+ years
Brief Summary
After thyroid surgery, 0.6 to 4% of patients develop postoperative bleeding. 90% of this postoperative bleeding occurs within the first 48 hours. Most of the time, the complications are rapidly progre...
Eligibility Criteria
Inclusion
- Age ≥18 years.
- Indication for thyroid surgery (e.g. total thyroidectomy, subtotal resection, partial resection or lobectomy) in routine clinical care according to applicable medical guidelines using all adequate surgical approaches.
- Signed informed consent
Exclusion
- \- Intended use of drains
Key Trial Info
Start Date :
October 23 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 24 2024
Estimated Enrollment :
1470 Patients enrolled
Trial Details
Trial ID
NCT04845867
Start Date
October 23 2023
End Date
November 24 2024
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Krankenhaus Agatharied
Hausham, Germany, 83734